Lisa Sullivan

Active 1987–2023

133
Papers
39,212
Citations
100
h-index
132
i10-index

Citations

Citations per year for Lisa Sullivan1988: 7 citations1989: 5 citations1990: 14 citations1991: 13 citations1992: 9 citations1993: 10 citations1994: 20 citations1995: 18 citations1996: 8 citations1997: 18 citations1998: 22 citations1999: 20 citations2000: 35 citations2001: 36 citations2002: 44 citations2003: 107 citations2004: 150 citations2005: 186 citations2006: 269 citations2007: 330 citations2008: 403 citations2009: 392 citations2010: 460 citations2011: 412 citations2012: 458 citations2013: 467 citations2014: 401 citations2015: 372 citations2016: 363 citations2017: 319 citations2018: 294 citations2019: 932 citations2020: 956 citations2021: 784 citations2022: 605 citations2023: 359 citations2024: 556 citations2025: 267 citations2026: 11 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,894 citing papers, 31.4% of this breakdownUnited Kingdom: 1,191 citing papers, 7.6% of this breakdownChina: 850 citing papers, 5.4% of this breakdownCanada: 735 citing papers, 4.7% of this breakdownItaly: 634 citing papers, 4.1% of this breakdownGermany: 620 citing papers, 4% of this breakdownAustralia: 557 citing papers, 3.6% of this breakdownNetherlands: 499 citing papers, 3.2% of this breakdownFrance: 417 citing papers, 2.7% of this breakdownSpain: 388 citing papers, 2.5% of this breakdownJapan: 340 citing papers, 2.2% of this breakdownSweden: 315 citing papers, 2% of this breakdown
0%31.4%Other 26.6%

Fields

  • Medicine72.4%
  • Biochemistry, Genetics and Molecular Biology10.8%
  • Neuroscience4.7%
  • Health Professions2.4%
  • Nursing2.2%
  • Social Sciences1.9%
  • Other5.6%

Topics

  • Diabetes, Cardiovascular Risks, and Lipoproteins4.7%
  • Adipokines, Inflammation, and Metabolic Diseases2.3%
  • Cardiovascular Function and Risk Factors2.1%
  • Atrial Fibrillation Management and Outcomes2%
  • Lipoproteins and Cardiovascular Health1.6%
  • Diet and metabolism studies1.6%
  • Other85.7%

Coauthors

All papers

Open in search
  1. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 759

  2. Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus

    Authors: , , , , - Circulation 2005 cited by 2,083

  3. Presentation of multivariate data for clinical use: The Framingham Study risk score functions

    Authors: , , - Statistics in Medicine 2004 cited by 1,758

  4. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

    Authors: , , , , - 2002 cited by 1,931

  5. Validation of the Framingham Coronary Heart Disease Prediction Scores

    Authors: , , , , - JAMA 2001 cited by 2,112

  6. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

    Authors: , , , , , - 2007 cited by 979

  7. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

    Authors: , , , , , , , , , , , , , , , - The Lancet 2009 cited by 1,053

  8. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease

    Authors: , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2006 cited by 1,059

  9. Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction

    Authors: , , , , , , , , , - Circulation 2003 cited by 743

  10. Revised Framingham Stroke Risk Profile to Reflect Temporal Trends

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation 2017 cited by 217

  11. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL management

    Authors: , , , , , , , - Journal of clinical lipidology 2007 cited by 437

  12. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double‐blind, placebo‐controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2011 cited by 924

  13. Obesity, diabetes and cognitive deficit: The Framingham Heart Study

    Authors: , , , , - Neurobiology of Aging 2005 cited by 391

  14. Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics

    Authors: , , - Statistics in Medicine 2002 cited by 716

  15. Effect of Aging on A1C Levels in Individuals Without Diabetes

    Authors: , , , , , , , , - Diabetes Care 2008 cited by 378

  16. Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women

    Authors: , , , , , , , , , , - JAMA 2007 cited by 606

  17. Correlates of Echocardiographic Indices of Cardiac Remodeling Over the Adult Life Course

    Authors: , , , , , , , - Circulation 2010 cited by 278

  18. New Norms for a New Generation: Cognitive Performance in the Framingham Offspring Cohort

    Authors: , , , , , , , - Experimental Aging Research 2004 cited by 145

  19. Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior

    Authors: , , , , , , , , , , , , - Archives of General Psychiatry 2009 cited by 477

  20. A parallel and distributed‐processing model of joint attention, social cognition and autism

    Authors: , , - Autism Research 2009 cited by 369

  21. The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality

    Authors: , , , - Diabetes Care 2004 cited by 319

  22. Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant Glioblastomas

    Authors: , , , , , , , , - Brain Pathology 2013 cited by 223

  23. Plasma Leptin Levels and Incidence of Heart Failure, Cardiovascular Disease, and Total Mortality in Elderly Individuals

    Authors: , , , , , , , , , , - Diabetes Care 2008 cited by 127

  24. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

    Authors: , , , , , , , , , - Schizophrenia Research 2005 cited by 1,139